InvestorsHub Logo
Followers 7
Posts 154
Boards Moderated 0
Alias Born 05/02/2006

Re: MyFiveCents post# 279945

Monday, 11/02/2020 5:17:44 PM

Monday, November 02, 2020 5:17:44 PM

Post# of 459455
MyFiveCents, this is the title of the CTAD presentation, so I think we have an idea about what sort of data will be presented.

LB25 - ANAVEX®2-73 (blarcamesine) Currently in Phase 2b/3 Early Alzheimer’s Disease (AD): Analysis of Cognitive Outcome Measures Relevant in AD of Double-blind, Multicenter, Placebo-controlled Phase 2 Clinical Trial in 132 Patients with Parkinson’s Disease Dementia

See page 18 at https://www.ctad-alzheimer.com/files/files/DIGITALprogram_CTAD2020_2nov.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News